Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Initial Genomic Analysis of a Pure Erythroid Leukemia Developing in Association with Hydroyurea Treatment for Sickle Cell Anemia

Zhengyuan Wang, Ph.D., Deepika S. Darbari, M.D., J. Joseph Melenhorst, Ph.D., Zachariah A. McIver, DO, Irina Maric, MD, Lena Diaw, Ph.D., Young Song, Ph.D., Peter Johansson, Ph.D., Jianbin He, Ph.D., Zhou Weiyin, Ph.D., Kevin B. Jacobs, M.S., Jun Wei, Ph.D., A. John Barrett, MD, Javed Khan, M.D., James G. Taylor, M.D.

Blood (2012) 120 (21): 3254.

https://doi.org/10.1182/blood.V120.21.3254.3254

Published: 2012

Journal Articles

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Sawa Ito, MD, Minoo Battiwalla, MD, MS, J. Joseph Melenhorst, Ph.D., Mattias Carlsten, MD Ph.D, Angelique Biancotto, PhD, Ena Wang, M.D., Zhi Xie, Ph.D., Pawel Muranski, MD, Matthew J. Olnes, MD, PhD, Kazushi Tanimoto, MD, Paula Schum, R.N., Shira Perl, MD, Howard Dickler, MD, J. Philip McCoy, PhD, Thomas Hughes, Pharm D, Leodayan Bojanowski, DNP, CIP, RN, Nancy F. Hensel, BS, Neal S. Young, MD, A. John Barrett, MD

Blood (2012) 120 (21): 3283.

https://doi.org/10.1182/blood.V120.21.3283.3283

Published: 2012

Journal Articles

Long Term Maintenance of Myeloid Leukemia Stem Cell-Like Populations Cultured with Mesenchymal Stromal Cells (MSC)

Sawa Ito, MD, A. John Barrett, MD, Andre Larochelle, M.D., Ph.D., Nancy F. Hensel, BS, Keyvan Keyvanfar, BS, J. Joseph Melenhorst, Ph.D.

Blood (2012) 120 (21): 3546.

https://doi.org/10.1182/blood.V120.21.3546.3546

Published: 2012

Journal Articles

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Sawa Ito, MD, Stephen A. Strickland, MD, MSCI, Bipin N. Savani, MD, J. Joseph Melenhorst, Ph.D., Fang Yin, MD, Pawel Muranski, MD, Nancy F. Hensel, BS, Fariba Chinian, M.S., Keyvan Keyvanfar, BS, Christopher S. Hourigan, MD, PhD, Minoo Battiwalla, MD, MS, A. John Barrett, MD

Blood (2012) 120 (21): 2528.

https://doi.org/10.1182/blood.V120.21.2528.2528

Published: 2012

Journal Articles

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

J. Joseph Melenhorst, Ph.D., Phillip Scheinberg, MD, Ann Williams, Keyvan Keyvanfar, Melody Smith, J. Philip McCoy, Jr., PhD, Nancy F. Hensel, A. John Barrett, MD

Blood (2009) 114 (22): 2439.

https://doi.org/10.1182/blood.V114.22.2439.2439

Published: 2009

Journal Articles

C-KIT with D816Y/V Mutations Cooperate with CBFB-MYH11 to Accelerate Leukemogenesis in Mice.

Ling Zhao, J. Joseph Melenhorst, Ph.D., Lemlem Alemu, Martha Kirby, Stacie M Anderson, Shelley Hoogstraten-Miller, Yasuhiko Kamikubo, MD, PhD, D. Gary Gilliland, MD, PhD, Pu Paul Liu

Blood (2009) 114 (22): 274.

https://doi.org/10.1182/blood.V114.22.274.274

Published: 2009

Journal Articles

Long-Term T Cell Immune Reconstitution in Patients Surviving 10 or More Years after Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Quan Le, MD, PhD, J. Joseph Melenhorst, Ph.D., Bipin N. Savani, MD, Brenna Hill, MPHIL, Sarfraz Memon, MD, Aarthi Shenoy, MD, Nancy F. Hensel, Elefteria K Koklanaris, RN, BSN, Keyvan Keyvanfar, BS, Fran Hakim, Ph.D., Daniel Douek, MD, PhD, A. John Barrett, MD

Blood (2008) 112 (11): 1173.

https://doi.org/10.1182/blood.V112.11.1173.1173

Published: 2008

NARROW

Initial Genomic Analysis of a Pure Erythroid Leukemia Developing in Association with Hydroyurea Treatment for Sickle Cell Anemia

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Long Term Maintenance of Myeloid Leukemia Stem Cell-Like Populations Cultured with Mesenchymal Stromal Cells (MSC)

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

C-KIT with D816Y/V Mutations Cooperate with CBFB-MYH11 to Accelerate Leukemogenesis in Mice.

Long-Term T Cell Immune Reconstitution in Patients Surviving 10 or More Years after Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

Initial Genomic Analysis of a Pure Erythroid Leukemia Developing in Association with Hydroyurea Treatment for Sickle Cell Anemia

Ultra-Low Dose IL-2 Safely Expands Regulatory T Cells and CD56 bright NK Cells in Healthy Volunteers: Towards Safer Stem Cell Donors?

Long Term Maintenance of Myeloid Leukemia Stem Cell-Like Populations Cultured with Mesenchymal Stromal Cells (MSC)

Myeloid-Derived Suppressor Phenotype of Leukemic Blasts in Association with Increased Suppressor T Cell Subsets in Acute Myelogenous Leukemia– Evidence for Immunoediting.

Both Naïve and Memory T-Cell Subsets Participate in Alloresponses to HLA-Mismatched Targets – Implications for Adoptive Transfer of Viral Antigen-Specific T Cells.

C-KIT with D816Y/V Mutations Cooperate with CBFB-MYH11 to Accelerate Leukemogenesis in Mice.

Long-Term T Cell Immune Reconstitution in Patients Surviving 10 or More Years after Allogeneic Stem Cell Transplantation for Hematologic Malignancies

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only